Stocks

Pfizer PFE

Health care sectorNYSE

Close
$28.73
09/29 close
Day change
−0.1%
vs previous close
Volume
1,789,126
−20.2% vs 30-day average
52-week range
$23.62$29.12
1-year return
+20.5%
vs the close a year ago
Market cap
$163.8B
5,699,673,589 shares · reported 07/29

Company

Exchange
NYSE
Industry
Pharmaceutical Preparations
Headquarters
New York, New York
Fiscal year end
12/31
Next earnings
11/03, estimated

Members of Congress reported 5 trades in Pfizer PFE in the past 90 days (0 purchases, 5 sales).

Korean holdings rank
Outside the top 50
Korea Securities Depository · released 09/22
Congress trades
5
Last 90 days · 0 buys · 5 sales
Insider net buying
No record
Last 90 days · 0 buys · 0 sales
Next earnings
11/03
Estimated from the last four quarters

Price

$28.73Day −0.1%1 year +20.5%

26-week trading

Common questions

Which members of Congress traded Pfizer PFE recently?
The latest reported trades: Rep. Carol Miller, full sale on 25/03/10 (reported 08/13), Rep. Michael Rulli, full sale on 24/11/26 (reported 08/07), Sen. Tommy Tuberville, full sale on 24/05/03 (reported 08/05), Sen. Alan Armstrong, full sale on 03/24 (reported 07/21) and Sen. Tommy Tuberville, full sale on 06/08 (reported 07/16).